Skip to content

भाषा बदलें: हिंदी में

mTatva Health-PIE

Search for:

Home
Health Articles
Disease Facts
Drug Facts – Brands
Drug Facts – Generics

Category: ANTI-PD-1 MONOCLONAL ANTIBODIES

Drug Classification

PEMBROLIZUMAB

September 13, 2018 mTatva Health

PEMBROLIZUMAB is a Schedule H drug.

ANTI-PD-1 MONOCLONAL ANTIBODIESmedicine for cervical cancer, medicine for head cancer, medicine for hodgkin s disease, medicine for neck cancer, medicine for non small cell lung cancer, medicine for skin cancer, medicine for stomach cancer

NIVOLUMAB

September 13, 2018 mTatva Health

NIVOLUMAB is a Schedule H drug.

ANTI-PD-1 MONOCLONAL ANTIBODIESmedicine for bladder cancer, medicine for colorectal cancer, medicine for head and neck cancer, medicine for kidney cancer, medicine for liver cancer, medicine for melanoma, medicine for non hodgkin lymphoma, medicine for non small cell lung cancer

Like us

Top Posts & Pages

Abscess: Symptom and Causes
CALCIMAX TAB
Leptospirosis: Treatment, Diet and Home Remedies
Polio: Symptom and Causes
GAVINDEX FORTE CAP
CETAPIN XR 500MG TAB
Myalgia: Meaning, Diagnosis and Overview
LIZOPEN 600MG TAB
Cervical Spondylosis: Treatment, Diet and Home Remedies
METOCLOPRAMIDE INJ

Recent Posts

Games changers of Healthcare – AI and IoMT
ULTRAMED 325MG/37.5MG TAB
ULTRAM 325MG/37.5MG TAB
ULTRAGIN 500MG TAB
ULTRACET SEMI 162.5MG/18.75MG TAB
ULTRACET 325MG/37.5MG TAB
ULTRABEST 37.5MG/325MG TAB
ULTRA PLUS H 162.5MG/18.75MG TAB
ULTRA PLUS 325MG/37.5MG TAB
ULTIMIDE 750MG TAB
ULTIFIX PLUS TAB
ULTIFIX LB TAB
ULTIFIX CV 250MG/125MG TAB
ULTIFIX 50MG TAB DT
ULTIFIX 50MG DRY SYP
ULTIFIX 200MG TAB DT
ULTIFIX 100MG TAB DT
ULTICAN 150MG TAB
ULEEV 250MG TAB
UCO 150MG TAB

1 2 3 100MG TAB
1 2 3 25MG TAB
1 2 3 50MG TAB
1 AL 10MG TAB
1 AL 2.5MG SYP

Home
Health Articles
Disease Facts
Drug Facts – Brands
Drug Facts – Generics

Copyright Since 2013. All rights reserved @mTatva

Proudly powered by WordPress | Education Hub by WEN Themes

X

Your Personal Doctor on Mobile
Get 1000+ diseases comprehensive information on your mobile

Download App Now